Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co.

86-0431-87078891

Changchun BCHT Biotechnology Co.
HomeProductsInfluenza Vaccine

Influenza Vaccine

(Total 33 Products)
Influenza Vaccine Influenza  Epidemiology

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

During non-outbreak epidemics,3-5 million severe cases and 0.29-0.65million of deaths. It is generally susceptible to all ages, and the attack rate of influenza in adults is 10.7%. In some high epidemic seasons, the annual influenza infection rate...
Influenza Vaccine Finshed Product from BCHT

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

BCHT launched its Influenza Vaccine in recent years which is exclusively authorized by the WHO in China. Adverse Reactions The Phase III clinical trial was conducted in China, in which 4500 subjects in the age of 3 years (36 months) - 17 years old...
BCHT Influenza Vaccine Recommendations

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

One of the flu symptom is nasal blockage which not only makes people feel bad but also draw series of complications. Here we have BCHT's influenza vaccine, nasal spray, freeze-dried which targets to people aged between 3-17 years old. This vaccine...
BCHT Influenza Vaccine Eggs

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

In order to get protection before the high incidence season of influenza, vaccination should be carried out as soon as possible after the influenza vaccine is put on the market, and the vaccination should be completed before the end of October. If...
Influenza Vaccine Different Options

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

The immune response of the tetravalent influenza vaccine is not inferior to that of the trivalent influenza vaccine, and the addition of another type B component of the tetravalent influenza vaccine does not interfere with the immune response caused...
Influenza Vaccine Dose for 4 Year Old

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

The immunity of human body to influenza virus infection or vaccination will decline with time. The degree of attenuation is related to the age, physical condition, vaccine antigen and other factors. The evidence from clinical trials suggests that...
BCHT Influenza Vaccine Global Information

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

In 2020, BCHT launched its Influenza Vaccine, Live, Nasal, Freeze-dried which is exclusively authorized by the WHO in China. Objective: Protective efficacy(Main indicator) Safety(Expand the population) Immunogenicity(Exploring) Design: multicenter,...
BCHT Influenza Vaccine Famous Product

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

Changchun BCHT Biotechnology Co. (BCHT), as a leading, promising and listed company, launched its Influenza Vaccine, Live, Nasal, Freeze-dried in 2020 which is exclusively authorized by the WHO in China. This product has also been included in Global...
BCHT Influenza Vaccine Finished Product

Brand: BCHT

Packaging: in vial

Supply Ability: Excellent

Generally, it is appropriate to take influenza vaccine in September to November every year. Because most of the flu occurs from November to February of the following year, and the "guidelines on influenza vaccination in China" puts forward that...

China Influenza Vaccine Suppliers

Influenza Vaccine, Live, Nasal, Freeze-dried Exclusively authorized by the WHO in China WHO
Influenza Vaccine, Live, Nasal, Freeze-dried is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccines (GAP)[1]. Hundreds of millions of doses have been used in the world, and Changchun BCHT Biotechnology Co. has the exclusive right of production and

operation in China. 

Intranasal spray administration, no Injection and no pain


The vaccine is inoculated by nasal spray, equipped with nasal spray device, and only needs to spray once a year in two nostrils to prevent influenza.
Mucosal immunity + Cellular immunity + Humoral immunity

After influenza virus attacks human body, it widely exists in nasal cavity, respiratory tract and other mucosal parts, as well as in body fluids and cells.
Vaccination of Influenza Vaccine, Live, Nasal, Freeze-dried can quickly stimulate the triple immune response of human body, and carry out defense
against viruses in different parts:
·Intranasal administration can produce mucosal immunity (IgA antibody), which forms the first immune defense line in the nasal cavity.
·Produce humoral immunity (IgG antibody) to remove influenza virus from body fluids.
·Produce cellular immunity (T cells) to remove influenza virus from cells
 3+N More extensive protection
The production strains are recommended and supplied by the WHO every year.
The vaccine can not only effectively resist the vaccine strain, but also produce cross immunity to other subtypes of influenza virus.

Produced with SPF embryonated eggs


The chick embryos for vaccine production comes from SPF (specific pathogen free) chicken flocks, so the risk of exogenous pathogenic microorganism

pollution is excluded.


Free of inactivator, split agent and preservative

 High protection and fast antibody production

This is the first influenza vaccine in China that has been evaluated by the protection effect of etiology in clinical stage. The protective effect of phase III
clinical trial is consistent with the literature[2] .
First, the immune barrier was formed in the nasal mucosa after LAIV vaccination. It has been reported that the antibody of nasal mucosa can be
produced in 3 days[3], which greatly shortens the time for vaccine to produce
protective effect.
Home > Products > Influenza Vaccine

New Products

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send